NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/04/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization10.84 mln
Float60.23 mln
Earnings Date11/20/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
4.47
Transformational upside
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
-12.27
Negative equity
ROE
-12,227
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Medicus Pharma Ltd. is a life sciences company based in Conshohocken, Pennsylvania, focused on bringing new treatments to patients in the United States. Its lead program, SKNJCT-003, is currently in Phase 2 clinical trials as a potential treatment for basal cell carcinoma, a common form of skin cancer. The company has partnered with the Gorlin Syndrome Alliance to expand patient access to its SKINJECT therapy for those living with Gorlin Syndrome.
